Stay updated on Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial
Sign up to get notified when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.

Latest updates to the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.6.5, indicating an update to the revision history, and a large block of older content items from the previous revision appears to have been removed.SummaryDifference19%

- Check11 days agoChange DetectedThe ROCKIF trial record shows termination due to funding loss and cessation of enrollment, with results posted. The entry also documents changes to dosing arms and schedules while some contact information sections were removed.SummaryDifference5%

- Check18 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a backend/template update to the Study Details page. The change does not modify the study information or user-facing content.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page's revision label was updated to v3.6.3, replacing the previous v3.6.2, indicating a minor internal version increment.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page footer now shows Revision: v3.6.2 instead of v3.6.0, reflecting a system update. This change does not modify the study content or user-facing information beyond the version label.SummaryDifference0.1%

- Check54 days agoChange DetectedA set of indexing terms, regulatory data flags, and page metadata were removed from the study page, reducing searchable keywords and labels while leaving the core study details accessible.SummaryDifference18%

Stay in the know with updates to Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.